OVARIAN SEROUS TUMOR
Clinical trials for OVARIAN SEROUS TUMOR explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SEROUS TUMOR trials appear
Sign up with your email to follow new studies for OVARIAN SEROUS TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pill vs. IV drip: major trial tests easier treatment for returning ovarian cancer
Disease control OngoingThis large, late-stage trial is testing whether taking pills (olaparib alone or with cediranib) works as well or better than standard intravenous chemotherapy for women whose ovarian, fallopian tube, or primary peritoneal cancer has returned but still responds to platinum drugs. …
Matched conditions: OVARIAN SEROUS TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for Tough-to-Treat ovarian cancer?
Disease control OngoingThis study is testing if adding a new drug called M6620 to a standard chemotherapy (gemcitabine) works better than the chemotherapy alone for women with recurrent ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum drugs. The main goal is…
Matched conditions: OVARIAN SEROUS TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC